Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00222404 |
Date of registration:
|
14/09/2005 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"
Pharmacogenos |
Scientific title:
|
Pharmacogenomic Study Realized Within the Framework of the Common Care to "Non-small Cell Lung Carcinoma" at Any Stages Treated by Chemotherapy. |
Date of first enrolment:
|
July 2005 |
Target sample size:
|
556 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00222404 |
Study type:
|
Observational |
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
Chritian Brambilla, Pr. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
INSERM U578 |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patient older than 18 suffering from Non-Small-Cell Lung Carcinoma
- Patient treated by chemotherapy with platinum salt
- Every stage TNM classification
- No previous chemotherapy
- One measurable lesion out of nervous central system at least
- Performance status from 0 to 2 on ECOG scale
- Life expectancy > 12 weeks
Exclusion Criteria:
- Previous or Concomitant carcinoma over 5 last years
- Concomitant radiotherapy
- Cardiac disease
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Carcinoma, Non-Small-Cell Lung
|
Secondary ID(s)
|
DCIC 04 40
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|